Inclusion criteria included articles published in the last two decades (2000-2020), written in English, incorporated statin or PCSK9 inhibitors as therapy for hyperlipidemia, and compared these treatments to genders and or race. The gene discussed is PCSK9; the disease is hyperlipidemia.